Cargando…

Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA

Detalles Bibliográficos
Autores principales: Sharma, Amit, Marshall, Thomas S., Khan, Samina S., Johns, Beverly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079386/
http://dx.doi.org/10.1007/s40261-013-0165-y
_version_ 1782323841617362944
author Sharma, Amit
Marshall, Thomas S.
Khan, Samina S.
Johns, Beverly
author_facet Sharma, Amit
Marshall, Thomas S.
Khan, Samina S.
Johns, Beverly
author_sort Sharma, Amit
collection PubMed
description
format Online
Article
Text
id pubmed-4079386
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-40793862014-07-25 Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA Sharma, Amit Marshall, Thomas S. Khan, Samina S. Johns, Beverly Clin Drug Investig Erratum Springer International Publishing 2014-01-03 2014 /pmc/articles/PMC4079386/ http://dx.doi.org/10.1007/s40261-013-0165-y Text en © Springer International Publishing Switzerland 2013
spellingShingle Erratum
Sharma, Amit
Marshall, Thomas S.
Khan, Samina S.
Johns, Beverly
Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
title Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
title_full Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
title_fullStr Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
title_full_unstemmed Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
title_short Erratum to: Cost Effectiveness of Paricalcitol Versus Cinacalcet with Low-Dose Vitamin D for Management of Secondary Hyperparathyroidism in Haemodialysis Patients in the USA
title_sort erratum to: cost effectiveness of paricalcitol versus cinacalcet with low-dose vitamin d for management of secondary hyperparathyroidism in haemodialysis patients in the usa
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079386/
http://dx.doi.org/10.1007/s40261-013-0165-y
work_keys_str_mv AT sharmaamit erratumtocosteffectivenessofparicalcitolversuscinacalcetwithlowdosevitamindformanagementofsecondaryhyperparathyroidisminhaemodialysispatientsintheusa
AT marshallthomass erratumtocosteffectivenessofparicalcitolversuscinacalcetwithlowdosevitamindformanagementofsecondaryhyperparathyroidisminhaemodialysispatientsintheusa
AT khansaminas erratumtocosteffectivenessofparicalcitolversuscinacalcetwithlowdosevitamindformanagementofsecondaryhyperparathyroidisminhaemodialysispatientsintheusa
AT johnsbeverly erratumtocosteffectivenessofparicalcitolversuscinacalcetwithlowdosevitamindformanagementofsecondaryhyperparathyroidisminhaemodialysispatientsintheusa